Event

Insilico Medicine lists on the Hong Kong Stock Exchange

Global · Capital

Type
Capital
Market
Global
When
30 December 2025

What to watch

Why variis flagged this

HK$2.28B raised (HKEX:3696), the largest 2025 Hong Kong biotech listing; Temasek held a cornerstone position.

Related

Entities in play

Common questions

Insilico Medicine lists on the Hong Kong Stock Exchange: what happened?
HK$2.28B raised (HKEX:3696), the largest 2025 Hong Kong biotech listing; Temasek held a cornerstone position.
Insilico Medicine lists on the Hong Kong Stock Exchange: when?
30 December 2025. variis records dates only to the precision the source published, so a date given here as a month or a year is not being rounded from something more exact.
Insilico Medicine lists on the Hong Kong Stock Exchange: who is involved?
Insilico Medicine
Insilico Medicine lists on the Hong Kong Stock Exchange: why does variis track it?
It is recorded as capital, one of the categories variis follows across the longevity market.

Keep reading

Related coverage from the newsroom.

Lecture hall session at NUS's Intensive Course on Healthy Longevity launched alongside its new Healthy Longevity Graduate Certificate Singapore.

Singapore · Industry

NUS launches healthy longevity graduate certificate

Morrow's founder Allen Law, argue that longevity care can move beyond elite clinics through lifestyle medicine and AI-powered approaches.

Singapore · Industry

Can longevity be designed for everyone, not just the wealthy?

Prof. Andrea B. Maier in a research laboratory at NUS, Co-Founder of the NUS Academy for Healthy Longevity, advancing Singapore's healthy longevity research.

Singapore · Industry

Singapore pushes clinical longevity care into the mainstream

Suggest an update

Every entity profile on variis is sourced. Not medical or investment advice.